Latest Articles
- Persistent erosions of the glans penis and foreskin
A 66-year-old man presented with an 8-month history of persistent erosions of the glans penis and foreskin with slight itching and pain.
- Foxglove, not quite gone or forgotten
Digoxin use has waned dramatically over the past decades, with good reason, but for select patients, it may be a very reasonable option.
- What fluids should I order for my patient with acute pancreatitis?
Recent data show that moderate fluid resuscitation is associated with fewer adverse events and that lactated Ringer’s may be superior to normal saline.
- Recurrent syncope in a 62-year-old man
The patient experienced 2 episodes of syncope over 4 weeks, had a history of recurrent carpal tunnel syndrome, and had ankle edema for the previous 18 months.
- Helicobacter pylori: A concise review of the latest treatments against an old foe
H pylori eradication regimens are tailored based on the presence of effective empiric therapy (local cure rates ≥ 90% for a given regimen) or antimicrobial susceptibility testing.
- Digoxin is still useful, but is still causing toxicity
The authors review the presentation of digoxin toxicity, its mechanisms and predisposing factors, and its medical management.
SGLT-2 inhibitors in heart failure and chronic kidney disease: A review for internistsThis review summarizes recent data and guidelines regarding SGLT-2 inhibitors in heart failure and chronic kidney disease and provides practical guidance for their use.
- Lymphedema vs lipedema: Similar but different
Lymphedema, lipedema, and even simple obesity in the extremities can resemble each other superficially and are often confused for one another, but they differ in important ways.
- Do patients with sepsis benefit from intravenous albumin?
Patients with sepsis who do not need vasopressors do not benefit from intravenous albumin compared with intravenous crystalloid therapy alone.
- SGLT-2 inhibitors: Diabetes and CKD and CHF (and gout?), oh my!
What mechanisms might account for the diverse beneficial effects of the SGLT-2 inhibitors observed across various diseases?